

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein neddylation (GO:0045116) | 5.99055104 |
| 2 | fatty acid elongation (GO:0030497) | 4.80505617 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 4.39086757 |
| 4 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 4.37605174 |
| 5 | vitamin transmembrane transport (GO:0035461) | 4.24074081 |
| 6 | L-serine metabolic process (GO:0006563) | 4.21205572 |
| 7 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.15937807 |
| 8 | biotin metabolic process (GO:0006768) | 4.07572524 |
| 9 | alpha-linolenic acid metabolic process (GO:0036109) | 3.96101853 |
| 10 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.93235651 |
| 11 | acyl-CoA biosynthetic process (GO:0071616) | 3.90587613 |
| 12 | thioester biosynthetic process (GO:0035384) | 3.90587613 |
| 13 | cholesterol biosynthetic process (GO:0006695) | 3.90498973 |
| 14 | folic acid transport (GO:0015884) | 3.84235535 |
| 15 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.80102903 |
| 16 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.76949089 |
| 17 | respiratory electron transport chain (GO:0022904) | 3.70323655 |
| 18 | electron transport chain (GO:0022900) | 3.70294280 |
| 19 | heme transport (GO:0015886) | 3.67075744 |
| 20 | DNA deamination (GO:0045006) | 3.60296187 |
| 21 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.58288960 |
| 22 | ATP synthesis coupled proton transport (GO:0015986) | 3.58288960 |
| 23 | autophagic vacuole fusion (GO:0000046) | 3.55977906 |
| 24 | protein complex biogenesis (GO:0070271) | 3.49050037 |
| 25 | serine family amino acid biosynthetic process (GO:0009070) | 3.48605565 |
| 26 | pantothenate metabolic process (GO:0015939) | 3.47620409 |
| 27 | sterol biosynthetic process (GO:0016126) | 3.47060282 |
| 28 | triglyceride biosynthetic process (GO:0019432) | 3.46066577 |
| 29 | cofactor transport (GO:0051181) | 3.44866234 |
| 30 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.39776267 |
| 31 | proteasome assembly (GO:0043248) | 3.37360814 |
| 32 | NADH metabolic process (GO:0006734) | 3.34797510 |
| 33 | creatine metabolic process (GO:0006600) | 3.29581398 |
| 34 | acylglycerol biosynthetic process (GO:0046463) | 3.27841931 |
| 35 | neutral lipid biosynthetic process (GO:0046460) | 3.27841931 |
| 36 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.26409079 |
| 37 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.26409079 |
| 38 | NADH dehydrogenase complex assembly (GO:0010257) | 3.26409079 |
| 39 | adhesion of symbiont to host (GO:0044406) | 3.23985131 |
| 40 | negative regulation of heart rate (GO:0010459) | 3.23520339 |
| 41 | regulation of cholesterol metabolic process (GO:0090181) | 3.21571834 |
| 42 | amino acid salvage (GO:0043102) | 3.20113145 |
| 43 | L-methionine salvage (GO:0071267) | 3.20113145 |
| 44 | L-methionine biosynthetic process (GO:0071265) | 3.20113145 |
| 45 | purine-containing compound salvage (GO:0043101) | 3.20036180 |
| 46 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.19040874 |
| 47 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.18614848 |
| 48 | virion attachment to host cell (GO:0019062) | 3.17149531 |
| 49 | adhesion of symbiont to host cell (GO:0044650) | 3.17149531 |
| 50 | xenobiotic catabolic process (GO:0042178) | 3.15682725 |
| 51 | platelet dense granule organization (GO:0060155) | 3.13067899 |
| 52 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.11851480 |
| 53 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.10589244 |
| 54 | organelle membrane fusion (GO:0090174) | 3.05086527 |
| 55 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.04039114 |
| 56 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.01775722 |
| 57 | serine family amino acid metabolic process (GO:0009069) | 2.98916142 |
| 58 | axon ensheathment in central nervous system (GO:0032291) | 2.98207498 |
| 59 | central nervous system myelination (GO:0022010) | 2.98207498 |
| 60 | very long-chain fatty acid metabolic process (GO:0000038) | 2.98175605 |
| 61 | cytidine deamination (GO:0009972) | 2.96786581 |
| 62 | cytidine metabolic process (GO:0046087) | 2.96786581 |
| 63 | cytidine catabolic process (GO:0006216) | 2.96786581 |
| 64 | cysteine metabolic process (GO:0006534) | 2.96026449 |
| 65 | acetyl-CoA metabolic process (GO:0006084) | 2.94653341 |
| 66 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.94529146 |
| 67 | branched-chain amino acid catabolic process (GO:0009083) | 2.94232651 |
| 68 | serine family amino acid catabolic process (GO:0009071) | 2.94225037 |
| 69 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.93383742 |
| 70 | granulocyte activation (GO:0036230) | 2.92343566 |
| 71 | L-phenylalanine catabolic process (GO:0006559) | 2.91873618 |
| 72 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.91873618 |
| 73 | regulation of platelet activation (GO:0010543) | 2.91737279 |
| 74 | modified amino acid transport (GO:0072337) | 2.91424754 |
| 75 | opsonization (GO:0008228) | 2.91206260 |
| 76 | neutrophil activation (GO:0042119) | 2.90702860 |
| 77 | thioester metabolic process (GO:0035383) | 2.90252719 |
| 78 | acyl-CoA metabolic process (GO:0006637) | 2.90252719 |
| 79 | sulfur amino acid catabolic process (GO:0000098) | 2.88898266 |
| 80 | glycine metabolic process (GO:0006544) | 2.88530227 |
| 81 | thrombin receptor signaling pathway (GO:0070493) | 2.87933539 |
| 82 | respiratory chain complex IV assembly (GO:0008535) | 2.87083015 |
| 83 | NADPH regeneration (GO:0006740) | 2.86840188 |
| 84 | nucleotide transmembrane transport (GO:1901679) | 2.83715342 |
| 85 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.82685230 |
| 86 | L-phenylalanine metabolic process (GO:0006558) | 2.82685230 |
| 87 | valine metabolic process (GO:0006573) | 2.82604277 |
| 88 | cytochrome complex assembly (GO:0017004) | 2.82271428 |
| 89 | response to mercury ion (GO:0046689) | 2.82133243 |
| 90 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.80786998 |
| 91 | linoleic acid metabolic process (GO:0043651) | 2.79848432 |
| 92 | hydrogen ion transmembrane transport (GO:1902600) | 2.78831597 |
| 93 | lipoxygenase pathway (GO:0019372) | 2.78776751 |
| 94 | regulation of oxidative phosphorylation (GO:0002082) | 2.78755755 |
| 95 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.78543471 |
| 96 | plasma lipoprotein particle clearance (GO:0034381) | 2.77833859 |
| 97 | cellular biogenic amine catabolic process (GO:0042402) | 2.76044958 |
| 98 | amine catabolic process (GO:0009310) | 2.76044958 |
| 99 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.75580972 |
| 100 | low-density lipoprotein particle clearance (GO:0034383) | 2.74618951 |
| 101 | pentose-phosphate shunt (GO:0006098) | 2.73653979 |
| 102 | regulation of platelet aggregation (GO:0090330) | 2.72171796 |
| 103 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.72088729 |
| 104 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.71936219 |
| 105 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.70164327 |
| 106 | positive regulation of mast cell activation (GO:0033005) | 2.69028269 |
| 107 | phosphatidic acid biosynthetic process (GO:0006654) | 2.67869114 |
| 108 | phosphatidic acid metabolic process (GO:0046473) | 2.67869114 |
| 109 | phagocytosis, recognition (GO:0006910) | 2.67344880 |
| 110 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.67157171 |
| 111 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.67157171 |
| 112 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.66718118 |
| 113 | iron coordination entity transport (GO:1901678) | 2.66480682 |
| 114 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.63958426 |
| 115 | purine nucleobase biosynthetic process (GO:0009113) | 2.62890078 |
| 116 | phagosome maturation (GO:0090382) | 2.62462100 |
| 117 | type B pancreatic cell proliferation (GO:0044342) | 2.61711708 |
| 118 | dopamine transport (GO:0015872) | 2.60882925 |
| 119 | glyoxylate metabolic process (GO:0046487) | 2.60554767 |
| 120 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.60536527 |
| 121 | regulation of metalloenzyme activity (GO:0048552) | 2.59973355 |
| 122 | proton transport (GO:0015992) | 2.59238156 |
| 123 | short-chain fatty acid metabolic process (GO:0046459) | 2.59047609 |
| 124 | regulation of sequestering of triglyceride (GO:0010889) | 2.57191663 |
| 125 | negative regulation of macroautophagy (GO:0016242) | 2.55609450 |
| 126 | triglyceride metabolic process (GO:0006641) | 2.55582556 |
| 127 | axon ensheathment (GO:0008366) | 2.55056289 |
| 128 | ensheathment of neurons (GO:0007272) | 2.55056289 |
| 129 | folic acid metabolic process (GO:0046655) | 2.55042616 |
| 130 | branched-chain amino acid metabolic process (GO:0009081) | 2.55041480 |
| 131 | isoprenoid biosynthetic process (GO:0008299) | 2.54174881 |
| 132 | urate metabolic process (GO:0046415) | 2.53652458 |
| 133 | myelination (GO:0042552) | 2.53314872 |
| 134 | hydrogen transport (GO:0006818) | 2.53034440 |
| 135 | glycosylceramide metabolic process (GO:0006677) | 2.52498046 |
| 136 | ethanol oxidation (GO:0006069) | 2.51668941 |
| 137 | cellular response to cholesterol (GO:0071397) | 2.51574187 |
| 138 | reverse cholesterol transport (GO:0043691) | 2.50420942 |
| 139 | autophagic vacuole assembly (GO:0000045) | 2.49555482 |
| 140 | purine nucleotide salvage (GO:0032261) | 2.49445945 |
| 141 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.49134388 |
| 142 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.48554955 |
| 143 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.48554955 |
| 144 | mitochondrial calcium ion transport (GO:0006851) | 2.48428112 |
| 145 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.48168374 |
| 146 | negative regulation of response to food (GO:0032096) | 2.46862904 |
| 147 | negative regulation of appetite (GO:0032099) | 2.46862904 |
| 148 | adenosine metabolic process (GO:0046085) | 2.46780903 |
| 149 | fatty acid beta-oxidation (GO:0006635) | 2.46624661 |
| 150 | vitamin transport (GO:0051180) | 2.45315294 |
| 151 | bile acid biosynthetic process (GO:0006699) | 2.45056483 |
| 152 | L-serine transport (GO:0015825) | 2.44194236 |
| 153 | amino-acid betaine metabolic process (GO:0006577) | 2.43713576 |
| 154 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.42849106 |
| 155 | superoxide anion generation (GO:0042554) | 2.42538789 |
| 156 | oxygen transport (GO:0015671) | 2.42513498 |
| 157 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.42402341 |
| 158 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.42356847 |
| 159 | protein-cofactor linkage (GO:0018065) | 2.40017542 |
| 160 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.38356826 |
| 161 | signal peptide processing (GO:0006465) | 2.38027195 |
| 162 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.36814527 |
| 163 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.36609658 |
| 164 | response to xenobiotic stimulus (GO:0009410) | 2.34715781 |
| 165 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.34587870 |
| 166 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.33939142 |
| 167 | response to interferon-beta (GO:0035456) | 2.33523516 |
| 168 | regulation of mast cell activation (GO:0033003) | 2.33225987 |
| 169 | leukocyte degranulation (GO:0043299) | 2.32069344 |
| 170 | heme metabolic process (GO:0042168) | 2.31452193 |
| 171 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.31250778 |
| 172 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.26717909 |
| 173 | eosinophil chemotaxis (GO:0048245) | 2.24596081 |
| 174 | phospholipid homeostasis (GO:0055091) | 2.23828358 |
| 175 | aromatic amino acid family catabolic process (GO:0009074) | 2.23749613 |
| 176 | ATP biosynthetic process (GO:0006754) | 2.23039238 |
| 177 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.22425546 |
| 178 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.22408558 |
| 179 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.22408558 |
| 180 | protein deneddylation (GO:0000338) | 2.21541082 |
| 181 | blood coagulation, intrinsic pathway (GO:0007597) | 2.21239770 |
| 182 | cellular metabolic compound salvage (GO:0043094) | 2.20383429 |
| 183 | porphyrin-containing compound metabolic process (GO:0006778) | 2.20361519 |
| 184 | low-density lipoprotein particle remodeling (GO:0034374) | 2.19279288 |
| 185 | glutathione derivative biosynthetic process (GO:1901687) | 2.18857386 |
| 186 | glutathione derivative metabolic process (GO:1901685) | 2.18857386 |
| 187 | tyrosine metabolic process (GO:0006570) | 2.18786822 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.57189402 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.31161423 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.58064737 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.55487045 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.35390624 |
| 6 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.15209046 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.09751923 |
| 8 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.01914471 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.00156130 |
| 10 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.96316464 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.84157597 |
| 12 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.71193468 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.66098362 |
| 14 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.65449977 |
| 15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.58708821 |
| 16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.57465498 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.48805768 |
| 18 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.45684651 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.45031539 |
| 20 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.35876341 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.33993640 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.30008294 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.23787956 |
| 24 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.20777280 |
| 25 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.14936701 |
| 26 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.13864383 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.13535513 |
| 28 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.09665395 |
| 29 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.08507936 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04999537 |
| 31 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.00863424 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89277359 |
| 33 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.88103237 |
| 34 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.87407527 |
| 35 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.87239447 |
| 36 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.86442575 |
| 37 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.84731794 |
| 38 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.82639262 |
| 39 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81266884 |
| 40 | GATA1_22025678_ChIP-Seq_K562_Human | 1.77619328 |
| 41 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.76393326 |
| 42 | VDR_22108803_ChIP-Seq_LS180_Human | 1.72924264 |
| 43 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.72299673 |
| 44 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.72249053 |
| 45 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.71729472 |
| 46 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.71238316 |
| 47 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.70110208 |
| 48 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.67838673 |
| 49 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.58582975 |
| 50 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.58469458 |
| 51 | GATA1_19941826_ChIP-Seq_K562_Human | 1.53425602 |
| 52 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.50304926 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46588993 |
| 54 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.46322431 |
| 55 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43889633 |
| 56 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.43769803 |
| 57 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.43669899 |
| 58 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.42971631 |
| 59 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.42042424 |
| 60 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.41709399 |
| 61 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.40601205 |
| 62 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.40407756 |
| 63 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.39723542 |
| 64 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39161197 |
| 65 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.39018184 |
| 66 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.37476826 |
| 67 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.36740719 |
| 68 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.36440385 |
| 69 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.34380923 |
| 70 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.33790854 |
| 71 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.33746255 |
| 72 | GATA3_26560356_Chip-Seq_TH2_Human | 1.28054324 |
| 73 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.26847269 |
| 74 | AR_20517297_ChIP-Seq_VCAP_Human | 1.26838971 |
| 75 | GATA2_19941826_ChIP-Seq_K562_Human | 1.25714499 |
| 76 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.25532066 |
| 77 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.25398799 |
| 78 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.23751879 |
| 79 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.22980541 |
| 80 | SPI1_23127762_ChIP-Seq_K562_Human | 1.22344609 |
| 81 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20858210 |
| 82 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.20720120 |
| 83 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.20228090 |
| 84 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.19051657 |
| 85 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.18880586 |
| 86 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.18356878 |
| 87 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.17852689 |
| 88 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.17219501 |
| 89 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.16624016 |
| 90 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.15276351 |
| 91 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14135348 |
| 92 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13506755 |
| 93 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.13463934 |
| 94 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.12710599 |
| 95 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.12444547 |
| 96 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.12444547 |
| 97 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.11515903 |
| 98 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.11453477 |
| 99 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.10241582 |
| 100 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.10207104 |
| 101 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.09933577 |
| 102 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.08729081 |
| 103 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08609838 |
| 104 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.08060673 |
| 105 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.07464035 |
| 106 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.07464035 |
| 107 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05504948 |
| 108 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.04882487 |
| 109 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.04882487 |
| 110 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.02449530 |
| 111 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01306962 |
| 112 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.00944648 |
| 113 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.99658938 |
| 114 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.98928423 |
| 115 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98658712 |
| 116 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.98280336 |
| 117 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.97894707 |
| 118 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97894561 |
| 119 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.97175677 |
| 120 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.97106671 |
| 121 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.96655722 |
| 122 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96392430 |
| 123 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.96279890 |
| 124 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94455609 |
| 125 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.94279975 |
| 126 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.94178710 |
| 127 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93619611 |
| 128 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.93490823 |
| 129 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.93222970 |
| 130 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91899205 |
| 131 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91772849 |
| 132 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.91299154 |
| 133 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.90950290 |
| 134 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90018479 |
| 135 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.89663508 |
| 136 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.88127307 |
| 137 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87898592 |
| 138 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.87377865 |
| 139 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.86937420 |
| 140 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86760447 |
| 141 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.85656038 |
| 142 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.85612642 |
| 143 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.85504125 |
| 144 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.85200576 |
| 145 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.83839686 |
| 146 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.83800467 |
| 147 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.83224514 |
| 148 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82572591 |
| 149 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.82257351 |
| 150 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81854194 |
| 151 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.81486821 |
| 152 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.80566994 |
| 153 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.80550978 |
| 154 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.80391494 |
| 155 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.80274717 |
| 156 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.78980021 |
| 157 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.78431930 |
| 158 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.77607866 |
| 159 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76714097 |
| 160 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.76569327 |
| 161 | ATF3_27146783_Chip-Seq_COLON_Human | 0.76511051 |
| 162 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.76357615 |
| 163 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.74654710 |
| 164 | CJUN_26792858_Chip-Seq_BT549_Human | 0.74498216 |
| 165 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.73949487 |
| 166 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.73649679 |
| 167 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.73160770 |
| 168 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.72422766 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 4.56373614 |
| 2 | MP0009840_abnormal_foam_cell | 4.46155059 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 4.42960909 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.45545815 |
| 5 | MP0003329_amyloid_beta_deposits | 3.35535469 |
| 6 | MP0005058_abnormal_lysosome_morphology | 3.33679365 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 2.72166951 |
| 8 | MP0000604_amyloidosis | 2.53270561 |
| 9 | MP0001542_abnormal_bone_strength | 2.45620996 |
| 10 | MP0000920_abnormal_myelination | 2.43280808 |
| 11 | MP0005332_abnormal_amino_acid | 2.43128948 |
| 12 | MP0005671_abnormal_response_to | 2.41962584 |
| 13 | MP0001661_extended_life_span | 2.40852254 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.38856676 |
| 15 | MP0003690_abnormal_glial_cell | 2.31877006 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.30942210 |
| 17 | MP0005360_urolithiasis | 2.30712499 |
| 18 | MP0003656_abnormal_erythrocyte_physiolo | 2.24271578 |
| 19 | MP0008260_abnormal_autophagy | 2.20857243 |
| 20 | MP0003186_abnormal_redox_activity | 2.01776272 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 1.99973163 |
| 22 | MP0008004_abnormal_stomach_pH | 1.99638760 |
| 23 | MP0009785_altered_susceptibility_to | 1.97709467 |
| 24 | MP0005451_abnormal_body_composition | 1.95665830 |
| 25 | MP0001958_emphysema | 1.82091518 |
| 26 | MP0009384_cardiac_valve_regurgitation | 1.80951848 |
| 27 | MP0002876_abnormal_thyroid_physiology | 1.80711159 |
| 28 | MP0010329_abnormal_lipoprotein_level | 1.80511171 |
| 29 | MP0009764_decreased_sensitivity_to | 1.70514796 |
| 30 | MP0003646_muscle_fatigue | 1.69313382 |
| 31 | MP0005365_abnormal_bile_salt | 1.67603854 |
| 32 | MP0005503_abnormal_tendon_morphology | 1.64693413 |
| 33 | MP0003718_maternal_effect | 1.63556856 |
| 34 | MP0003195_calcinosis | 1.60557137 |
| 35 | MP0004147_increased_porphyrin_level | 1.56459280 |
| 36 | MP0005000_abnormal_immune_tolerance | 1.55281063 |
| 37 | MP0003950_abnormal_plasma_membrane | 1.53900300 |
| 38 | MP0006082_CNS_inflammation | 1.52913155 |
| 39 | MP0002295_abnormal_pulmonary_circulatio | 1.52823761 |
| 40 | MP0003279_aneurysm | 1.51507450 |
| 41 | MP0010386_abnormal_urinary_bladder | 1.50987058 |
| 42 | MP0005275_abnormal_skin_tensile | 1.49250200 |
| 43 | MP0008875_abnormal_xenobiotic_pharmacok | 1.47940250 |
| 44 | MP0005085_abnormal_gallbladder_physiolo | 1.45694842 |
| 45 | MP0002118_abnormal_lipid_homeostasis | 1.45489418 |
| 46 | MP0002837_dystrophic_cardiac_calcinosis | 1.44476058 |
| 47 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.42754199 |
| 48 | MP0000747_muscle_weakness | 1.42584313 |
| 49 | MP0005171_absent_coat_pigmentation | 1.41499548 |
| 50 | MP0003724_increased_susceptibility_to | 1.40500897 |
| 51 | MP0005410_abnormal_fertilization | 1.39218141 |
| 52 | MP0008872_abnormal_physiological_respon | 1.36626126 |
| 53 | MP0000685_abnormal_immune_system | 1.35162953 |
| 54 | MP0002723_abnormal_immune_serum | 1.35044780 |
| 55 | MP0005025_abnormal_response_to | 1.33636735 |
| 56 | MP0004130_abnormal_muscle_cell | 1.32078774 |
| 57 | MP0002736_abnormal_nociception_after | 1.31958559 |
| 58 | MP0004885_abnormal_endolymph | 1.29709001 |
| 59 | MP0001790_abnormal_immune_system | 1.29420858 |
| 60 | MP0005387_immune_system_phenotype | 1.29420858 |
| 61 | MP0000015_abnormal_ear_pigmentation | 1.28108397 |
| 62 | MP0005084_abnormal_gallbladder_morpholo | 1.28091503 |
| 63 | MP0005408_hypopigmentation | 1.27964466 |
| 64 | MP0000343_altered_response_to | 1.27114387 |
| 65 | MP0002132_abnormal_respiratory_system | 1.26807836 |
| 66 | MP0003303_peritoneal_inflammation | 1.26096533 |
| 67 | MP0002452_abnormal_antigen_presenting | 1.26022236 |
| 68 | MP0001845_abnormal_inflammatory_respons | 1.25531728 |
| 69 | MP0009643_abnormal_urine_homeostasis | 1.24551797 |
| 70 | MP0005319_abnormal_enzyme/_coenzyme | 1.23755113 |
| 71 | MP0003634_abnormal_glial_cell | 1.23008353 |
| 72 | MP0010155_abnormal_intestine_physiology | 1.22866302 |
| 73 | MP0003436_decreased_susceptibility_to | 1.21938158 |
| 74 | MP0000609_abnormal_liver_physiology | 1.20948735 |
| 75 | MP0005167_abnormal_blood-brain_barrier | 1.20866607 |
| 76 | MP0003705_abnormal_hypodermis_morpholog | 1.20625728 |
| 77 | MP0001800_abnormal_humoral_immune | 1.20310433 |
| 78 | MP0005164_abnormal_response_to | 1.19059618 |
| 79 | MP0006054_spinal_hemorrhage | 1.18777850 |
| 80 | MP0006036_abnormal_mitochondrial_physio | 1.15408416 |
| 81 | MP0005075_abnormal_melanosome_morpholog | 1.15267883 |
| 82 | MP0002420_abnormal_adaptive_immunity | 1.12581876 |
| 83 | MP0004272_abnormal_basement_membrane | 1.12338622 |
| 84 | MP0004510_myositis | 1.11832767 |
| 85 | MP0001819_abnormal_immune_cell | 1.11073376 |
| 86 | MP0000230_abnormal_systemic_arterial | 1.11054673 |
| 87 | MP0001533_abnormal_skeleton_physiology | 1.10552284 |
| 88 | MP0004019_abnormal_vitamin_homeostasis | 1.08690700 |
| 89 | MP0002090_abnormal_vision | 1.08265987 |
| 90 | MP0009763_increased_sensitivity_to | 1.07887170 |
| 91 | MP0003221_abnormal_cardiomyocyte_apopto | 1.07808381 |
| 92 | MP0005174_abnormal_tail_pigmentation | 1.06230669 |
| 93 | MP0001756_abnormal_urination | 1.05745238 |
| 94 | MP0003866_abnormal_defecation | 1.04632666 |
| 95 | MP0004858_abnormal_nervous_system | 1.00493107 |
| 96 | MP0005646_abnormal_pituitary_gland | 0.98628824 |
| 97 | MP0001968_abnormal_touch/_nociception | 0.97433139 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.96953820 |
| 99 | MP0008775_abnormal_heart_ventricle | 0.96914784 |
| 100 | MP0003638_abnormal_response/metabolism_ | 0.96541055 |
| 101 | MP0004142_abnormal_muscle_tone | 0.95972227 |
| 102 | MP0003172_abnormal_lysosome_physiology | 0.95813921 |
| 103 | MP0009333_abnormal_splenocyte_physiolog | 0.95513157 |
| 104 | MP0005330_cardiomyopathy | 0.95247151 |
| 105 | MP0000750_abnormal_muscle_regeneration | 0.95005766 |
| 106 | MP0004215_abnormal_myocardial_fiber | 0.92909085 |
| 107 | MP0005595_abnormal_vascular_smooth | 0.92482753 |
| 108 | MP0002332_abnormal_exercise_endurance | 0.91748608 |
| 109 | MP0001545_abnormal_hematopoietic_system | 0.91705127 |
| 110 | MP0005397_hematopoietic_system_phenotyp | 0.91705127 |
| 111 | MP0005377_hearing/vestibular/ear_phenot | 0.90827231 |
| 112 | MP0003878_abnormal_ear_physiology | 0.90827231 |
| 113 | MP0001853_heart_inflammation | 0.90478828 |
| 114 | MP0000647_abnormal_sebaceous_gland | 0.89950085 |
| 115 | MP0005636_abnormal_mineral_homeostasis | 0.89740090 |
| 116 | MP0003075_altered_response_to | 0.89563580 |
| 117 | MP0005395_other_phenotype | 0.88589628 |
| 118 | MP0000358_abnormal_cell_content/ | 0.88071857 |
| 119 | MP0005310_abnormal_salivary_gland | 0.88060946 |
| 120 | MP0002269_muscular_atrophy | 0.87542003 |
| 121 | MP0000689_abnormal_spleen_morphology | 0.86190802 |
| 122 | MP0003879_abnormal_hair_cell | 0.85958610 |
| 123 | MP0005535_abnormal_body_temperature | 0.85508600 |
| 124 | MP0002398_abnormal_bone_marrow | 0.85218414 |
| 125 | MP0002933_joint_inflammation | 0.84794461 |
| 126 | MP0004084_abnormal_cardiac_muscle | 0.84662060 |
| 127 | MP0004036_abnormal_muscle_relaxation | 0.84527764 |
| 128 | MP0008469_abnormal_protein_level | 0.82186876 |
| 129 | MP0001881_abnormal_mammary_gland | 0.81856767 |
| 130 | MP0000465_gastrointestinal_hemorrhage | 0.81664402 |
| 131 | MP0003632_abnormal_nervous_system | 0.81268055 |
| 132 | MP0001764_abnormal_homeostasis | 0.80302719 |
| 133 | MP0000372_irregular_coat_pigmentation | 0.79761182 |
| 134 | MP0001663_abnormal_digestive_system | 0.79742459 |
| 135 | MP0006138_congestive_heart_failure | 0.79165131 |
| 136 | MP0002419_abnormal_innate_immunity | 0.78639969 |
| 137 | MP0000749_muscle_degeneration | 0.78502163 |
| 138 | MP0000249_abnormal_blood_vessel | 0.77265311 |
| 139 | MP0003011_delayed_dark_adaptation | 0.76103916 |
| 140 | MP0001905_abnormal_dopamine_level | 0.75386791 |
| 141 | MP0001666_abnormal_nutrient_absorption | 0.74039946 |
| 142 | MP0005670_abnormal_white_adipose | 0.74017617 |
| 143 | MP0004185_abnormal_adipocyte_glucose | 0.73421150 |
| 144 | MP0004883_abnormal_blood_vessel | 0.72846891 |
| 145 | MP0000013_abnormal_adipose_tissue | 0.70600070 |
| 146 | MP0006035_abnormal_mitochondrial_morpho | 0.70396905 |
| 147 | MP0001243_abnormal_dermal_layer | 0.70055496 |
| 148 | MP0002971_abnormal_brown_adipose | 0.68842714 |
| 149 | MP0000598_abnormal_liver_morphology | 0.68815950 |
| 150 | MP0005666_abnormal_adipose_tissue | 0.68771059 |
| 151 | MP0005508_abnormal_skeleton_morphology | 0.66438453 |
| 152 | MP0002136_abnormal_kidney_physiology | 0.65999091 |
| 153 | MP0005083_abnormal_biliary_tract | 0.64619727 |
| 154 | MP0004134_abnormal_chest_morphology | 0.64428245 |
| 155 | MP0005165_increased_susceptibility_to | 0.63796271 |
| 156 | MP0005390_skeleton_phenotype | 0.63700957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Petechiae (HP:0000967) | 5.31196207 |
| 2 | Premature rupture of membranes (HP:0001788) | 4.82668123 |
| 3 | Prolonged bleeding time (HP:0003010) | 4.63408116 |
| 4 | 3-Methylglutaconic aciduria (HP:0003535) | 4.52694271 |
| 5 | Neurofibrillary tangles (HP:0002185) | 4.47889854 |
| 6 | Hyperglycinemia (HP:0002154) | 4.16018115 |
| 7 | Acute necrotizing encephalopathy (HP:0006965) | 4.08946537 |
| 8 | Hyperglycinuria (HP:0003108) | 4.02775130 |
| 9 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.93767383 |
| 10 | Abnormality of glycine metabolism (HP:0010895) | 3.90601843 |
| 11 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.90601843 |
| 12 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.79217010 |
| 13 | Mitochondrial inheritance (HP:0001427) | 3.74585362 |
| 14 | Generalized aminoaciduria (HP:0002909) | 3.64976038 |
| 15 | Acute encephalopathy (HP:0006846) | 3.61171286 |
| 16 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.57528592 |
| 17 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.57528592 |
| 18 | Progressive macrocephaly (HP:0004481) | 3.52989370 |
| 19 | Menorrhagia (HP:0000132) | 3.42910344 |
| 20 | Increased mean platelet volume (HP:0011877) | 3.37569323 |
| 21 | Renal Fanconi syndrome (HP:0001994) | 3.35012224 |
| 22 | Cerebral inclusion bodies (HP:0100314) | 3.33975762 |
| 23 | Increased CSF lactate (HP:0002490) | 3.33407128 |
| 24 | Xanthomatosis (HP:0000991) | 3.26412607 |
| 25 | Epistaxis (HP:0000421) | 3.24565806 |
| 26 | Abnormal platelet volume (HP:0011876) | 3.20682859 |
| 27 | Abnormality of glycolysis (HP:0004366) | 3.12444225 |
| 28 | Increased serum pyruvate (HP:0003542) | 3.12444225 |
| 29 | Muscle fiber splitting (HP:0003555) | 2.99586277 |
| 30 | Paralysis (HP:0003470) | 2.92305100 |
| 31 | Gout (HP:0001997) | 2.91275052 |
| 32 | Gingival bleeding (HP:0000225) | 2.86864195 |
| 33 | Hyperlipoproteinemia (HP:0010980) | 2.83439824 |
| 34 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.83426892 |
| 35 | Osteolytic defects of the hand bones (HP:0009699) | 2.83426892 |
| 36 | Cerebral hypomyelination (HP:0006808) | 2.82668309 |
| 37 | Spastic paraparesis (HP:0002313) | 2.81142633 |
| 38 | Poikilocytosis (HP:0004447) | 2.80075323 |
| 39 | Exertional dyspnea (HP:0002875) | 2.78738743 |
| 40 | Protrusio acetabuli (HP:0003179) | 2.75376569 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.74271027 |
| 42 | Increased intramyocellular lipid droplets (HP:0012240) | 2.71915189 |
| 43 | Stomatitis (HP:0010280) | 2.71736240 |
| 44 | Abnormality of serum amino acid levels (HP:0003112) | 2.69781599 |
| 45 | Cerebral edema (HP:0002181) | 2.55895593 |
| 46 | Increased muscle lipid content (HP:0009058) | 2.53755796 |
| 47 | Increased cerebral lipofuscin (HP:0011813) | 2.51897435 |
| 48 | Vacuolated lymphocytes (HP:0001922) | 2.50167512 |
| 49 | Lactic acidosis (HP:0003128) | 2.48951140 |
| 50 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.48808969 |
| 51 | Respiratory failure (HP:0002878) | 2.47666370 |
| 52 | Lipid accumulation in hepatocytes (HP:0006561) | 2.47201644 |
| 53 | Nonimmune hydrops fetalis (HP:0001790) | 2.45994289 |
| 54 | Increased hepatocellular lipid droplets (HP:0006565) | 2.45668469 |
| 55 | Paraparesis (HP:0002385) | 2.45207746 |
| 56 | Renal cortical cysts (HP:0000803) | 2.40744979 |
| 57 | Abnormality of the umbilical cord (HP:0010881) | 2.36942577 |
| 58 | Deep venous thrombosis (HP:0002625) | 2.36560725 |
| 59 | Prolonged neonatal jaundice (HP:0006579) | 2.35233336 |
| 60 | Hepatosplenomegaly (HP:0001433) | 2.35061420 |
| 61 | Abnormality of iron homeostasis (HP:0011031) | 2.34153182 |
| 62 | Hypochromic microcytic anemia (HP:0004840) | 2.33488861 |
| 63 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.31469289 |
| 64 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.31054753 |
| 65 | Dyschromatopsia (HP:0007641) | 2.30996907 |
| 66 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.30466920 |
| 67 | Cerebral hemorrhage (HP:0001342) | 2.30043505 |
| 68 | Vertebral compression fractures (HP:0002953) | 2.29824994 |
| 69 | Impaired platelet aggregation (HP:0003540) | 2.29381344 |
| 70 | Abnormal platelet function (HP:0011869) | 2.29381344 |
| 71 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.28120091 |
| 72 | Autoimmune hemolytic anemia (HP:0001890) | 2.26968121 |
| 73 | Abnormality of glycolipid metabolism (HP:0010969) | 2.26821903 |
| 74 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.26821903 |
| 75 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.26821903 |
| 76 | Tongue fasciculations (HP:0001308) | 2.26565871 |
| 77 | Irregular epiphyses (HP:0010582) | 2.26529942 |
| 78 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.25811572 |
| 79 | Axonal loss (HP:0003447) | 2.23177552 |
| 80 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.22933463 |
| 81 | Increased IgM level (HP:0003496) | 2.22224398 |
| 82 | Hyperammonemia (HP:0001987) | 2.20864847 |
| 83 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.20414823 |
| 84 | Abnormality of renal resorption (HP:0011038) | 2.16374554 |
| 85 | Increased serum lactate (HP:0002151) | 2.16072968 |
| 86 | Exercise intolerance (HP:0003546) | 2.15359011 |
| 87 | Dicarboxylic aciduria (HP:0003215) | 2.13968935 |
| 88 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.13968935 |
| 89 | Dysostosis multiplex (HP:0000943) | 2.12710790 |
| 90 | Abnormal hemoglobin (HP:0011902) | 2.11589488 |
| 91 | Increased serum ferritin (HP:0003281) | 2.09150716 |
| 92 | Glycosuria (HP:0003076) | 2.08055079 |
| 93 | Abnormality of urine glucose concentration (HP:0011016) | 2.08055079 |
| 94 | Abnormal pupillary function (HP:0007686) | 2.07262377 |
| 95 | Muscle fibrillation (HP:0010546) | 2.06853507 |
| 96 | Abnormal delivery (HP:0001787) | 2.06436765 |
| 97 | CNS demyelination (HP:0007305) | 2.05794927 |
| 98 | Autoimmune thrombocytopenia (HP:0001973) | 2.04459012 |
| 99 | Lethargy (HP:0001254) | 2.03389879 |
| 100 | Abnormality of lateral ventricle (HP:0030047) | 2.03254667 |
| 101 | Ankle contracture (HP:0006466) | 2.01408925 |
| 102 | Global brain atrophy (HP:0002283) | 2.01398399 |
| 103 | Tetraplegia (HP:0002445) | 1.99159956 |
| 104 | Delusions (HP:0000746) | 1.99084441 |
| 105 | Congenital, generalized hypertrichosis (HP:0004540) | 1.98860848 |
| 106 | Hypothermia (HP:0002045) | 1.98846856 |
| 107 | Cervical subluxation (HP:0003308) | 1.94794711 |
| 108 | Microcytic anemia (HP:0001935) | 1.93263815 |
| 109 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.93072499 |
| 110 | Autoamputation (HP:0001218) | 1.93065500 |
| 111 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.91936762 |
| 112 | Abnormality of alanine metabolism (HP:0010916) | 1.91936762 |
| 113 | Hyperalaninemia (HP:0003348) | 1.91936762 |
| 114 | Short nail (HP:0001799) | 1.91620984 |
| 115 | Type I transferrin isoform profile (HP:0003642) | 1.90875617 |
| 116 | Calcaneovalgus deformity (HP:0001848) | 1.90755817 |
| 117 | Tinnitus (HP:0000360) | 1.88346262 |
| 118 | Methylmalonic aciduria (HP:0012120) | 1.87197630 |
| 119 | Hypobetalipoproteinemia (HP:0003563) | 1.86467633 |
| 120 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.86267048 |
| 121 | Deformed tarsal bones (HP:0008119) | 1.86087722 |
| 122 | Optic disc pallor (HP:0000543) | 1.84285439 |
| 123 | Hypoglycemic coma (HP:0001325) | 1.84185628 |
| 124 | Degeneration of anterior horn cells (HP:0002398) | 1.83683935 |
| 125 | Abnormality of the anterior horn cell (HP:0006802) | 1.83683935 |
| 126 | Abnormality of the renal cortex (HP:0011035) | 1.83177618 |
| 127 | Hypoalphalipoproteinemia (HP:0003233) | 1.83005651 |
| 128 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.82171754 |
| 129 | Stridor (HP:0010307) | 1.81961482 |
| 130 | Obstructive lung disease (HP:0006536) | 1.81724763 |
| 131 | Chronic obstructive pulmonary disease (HP:0006510) | 1.81724763 |
| 132 | Polycythemia (HP:0001901) | 1.81717627 |
| 133 | Irritability (HP:0000737) | 1.81215983 |
| 134 | Hypolipoproteinemia (HP:0010981) | 1.80840035 |
| 135 | Biconcave vertebral bodies (HP:0004586) | 1.79751672 |
| 136 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.77967051 |
| 137 | Absent epiphyses (HP:0010577) | 1.77967051 |
| 138 | Hepatic necrosis (HP:0002605) | 1.77690857 |
| 139 | Acanthocytosis (HP:0001927) | 1.76953195 |
| 140 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.76243013 |
| 141 | Encephalitis (HP:0002383) | 1.75833827 |
| 142 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.75794149 |
| 143 | Recurrent abscess formation (HP:0002722) | 1.74974866 |
| 144 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.74517765 |
| 145 | Abnormal cartilage morphology (HP:0002763) | 1.72832870 |
| 146 | Flat capital femoral epiphysis (HP:0003370) | 1.72059605 |
| 147 | Split foot (HP:0001839) | 1.71037604 |
| 148 | Postnatal microcephaly (HP:0005484) | 1.70554284 |
| 149 | Albinism (HP:0001022) | 1.69653646 |
| 150 | Recurrent bacterial skin infections (HP:0005406) | 1.69419827 |
| 151 | Spastic tetraparesis (HP:0001285) | 1.68639761 |
| 152 | CNS hypomyelination (HP:0003429) | 1.68203812 |
| 153 | Epiphyseal stippling (HP:0010655) | 1.67209351 |
| 154 | Abnormality of purine metabolism (HP:0004352) | 1.66886885 |
| 155 | Abnormality of macrophages (HP:0004311) | 1.66548038 |
| 156 | Decreased central vision (HP:0007663) | 1.65749987 |
| 157 | Hyperuricemia (HP:0002149) | 1.65431413 |
| 158 | Increased purine levels (HP:0004368) | 1.65431413 |
| 159 | Stillbirth (HP:0003826) | 1.65406326 |
| 160 | Megalencephaly (HP:0001355) | 1.65214036 |
| 161 | Death in infancy (HP:0001522) | 1.64951130 |
| 162 | Peritonitis (HP:0002586) | 1.64670713 |
| 163 | X-linked dominant inheritance (HP:0001423) | 1.64415292 |
| 164 | Hepatocellular necrosis (HP:0001404) | 1.64257486 |
| 165 | Mitral stenosis (HP:0001718) | 1.63578097 |
| 166 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.63575556 |
| 167 | Abnormality of the Achilles tendon (HP:0005109) | 1.63220602 |
| 168 | Joint swelling (HP:0001386) | 1.63008888 |
| 169 | Atrioventricular block (HP:0001678) | 1.62631086 |
| 170 | Intrahepatic cholestasis (HP:0001406) | 1.61612410 |
| 171 | Supranuclear gaze palsy (HP:0000605) | 1.61412462 |
| 172 | Nausea (HP:0002018) | 1.61184718 |
| 173 | Soft skin (HP:0000977) | 1.60960837 |
| 174 | Purpura (HP:0000979) | 1.59515935 |
| 175 | Opisthotonus (HP:0002179) | 1.59486712 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 3.33642703 |
| 2 | STK39 | 3.28893573 |
| 3 | EIF2AK1 | 3.24155695 |
| 4 | BCKDK | 2.95756898 |
| 5 | TESK2 | 2.93082335 |
| 6 | NME2 | 2.88172154 |
| 7 | MAP3K12 | 2.80543819 |
| 8 | OXSR1 | 2.61060703 |
| 9 | TXK | 2.32175936 |
| 10 | PDK2 | 2.30678458 |
| 11 | ARAF | 2.26883254 |
| 12 | ADRBK2 | 2.26285782 |
| 13 | FRK | 2.25273927 |
| 14 | TAOK3 | 2.14423398 |
| 15 | PDK4 | 2.13078830 |
| 16 | PDK3 | 2.13078830 |
| 17 | EPHB1 | 2.00761623 |
| 18 | PIM2 | 1.94848812 |
| 19 | BMPR2 | 1.94212115 |
| 20 | TLK1 | 1.89434125 |
| 21 | KDR | 1.85726137 |
| 22 | MAP4K2 | 1.79395747 |
| 23 | PBK | 1.78805366 |
| 24 | LIMK1 | 1.78526357 |
| 25 | MAPKAPK3 | 1.77603790 |
| 26 | BMPR1B | 1.72086205 |
| 27 | TEC | 1.69451503 |
| 28 | TRIB3 | 1.67444509 |
| 29 | IKBKB | 1.61283594 |
| 30 | DDR2 | 1.55307877 |
| 31 | PINK1 | 1.52882733 |
| 32 | GRK5 | 1.50566986 |
| 33 | ABL2 | 1.49335349 |
| 34 | AKT3 | 1.40124343 |
| 35 | ERN1 | 1.38595128 |
| 36 | GRK6 | 1.34136378 |
| 37 | BLK | 1.31838278 |
| 38 | NEK1 | 1.30691056 |
| 39 | GRK1 | 1.29787377 |
| 40 | SYK | 1.23035265 |
| 41 | EIF2AK3 | 1.20383893 |
| 42 | PHKG2 | 1.19821167 |
| 43 | PHKG1 | 1.19821167 |
| 44 | CSNK1G3 | 1.19101537 |
| 45 | BTK | 1.18973348 |
| 46 | TIE1 | 1.16517128 |
| 47 | BMX | 1.15636299 |
| 48 | OBSCN | 1.15525116 |
| 49 | FGFR2 | 1.15460573 |
| 50 | TTN | 1.11573748 |
| 51 | BRAF | 1.11548523 |
| 52 | SIK1 | 1.10894990 |
| 53 | PLK2 | 1.10388909 |
| 54 | MAP3K3 | 1.07766389 |
| 55 | DAPK2 | 1.06993105 |
| 56 | GRK7 | 1.05279661 |
| 57 | WNK4 | 1.02522318 |
| 58 | ADRBK1 | 0.97232649 |
| 59 | ZAP70 | 0.96105811 |
| 60 | MAP2K6 | 0.95921356 |
| 61 | MOS | 0.95239138 |
| 62 | TRIM28 | 0.94838687 |
| 63 | LYN | 0.94237859 |
| 64 | LRRK2 | 0.94179228 |
| 65 | FES | 0.93096360 |
| 66 | LMTK2 | 0.92789813 |
| 67 | TAOK2 | 0.92672732 |
| 68 | VRK2 | 0.90938846 |
| 69 | TGFBR2 | 0.89450332 |
| 70 | CSF1R | 0.89389933 |
| 71 | CSNK1A1L | 0.89268266 |
| 72 | PDPK1 | 0.87747859 |
| 73 | CSNK1G1 | 0.87227477 |
| 74 | MYLK | 0.86301063 |
| 75 | PAK1 | 0.85989361 |
| 76 | CSNK1G2 | 0.85247549 |
| 77 | MAP2K3 | 0.84584226 |
| 78 | CDK19 | 0.83029197 |
| 79 | BCR | 0.82372697 |
| 80 | FGR | 0.81548244 |
| 81 | MAPK12 | 0.80618310 |
| 82 | MST1R | 0.80214008 |
| 83 | MARK3 | 0.78874221 |
| 84 | MET | 0.77591861 |
| 85 | MST4 | 0.77029039 |
| 86 | WEE1 | 0.75339623 |
| 87 | CAMK2G | 0.73732694 |
| 88 | HCK | 0.72913695 |
| 89 | KIT | 0.72474477 |
| 90 | ROCK2 | 0.72277845 |
| 91 | TNK2 | 0.71752595 |
| 92 | TSSK6 | 0.70580000 |
| 93 | MAP2K1 | 0.70510862 |
| 94 | STK3 | 0.70387862 |
| 95 | FER | 0.69323859 |
| 96 | IKBKE | 0.69145160 |
| 97 | IRAK1 | 0.69122502 |
| 98 | ILK | 0.69059335 |
| 99 | ICK | 0.68320178 |
| 100 | DYRK2 | 0.68185758 |
| 101 | DAPK1 | 0.67741370 |
| 102 | CAMKK2 | 0.67174258 |
| 103 | MAP3K5 | 0.66566000 |
| 104 | STK4 | 0.65961982 |
| 105 | PAK3 | 0.64495470 |
| 106 | ITK | 0.63671405 |
| 107 | NEK9 | 0.63631780 |
| 108 | VRK1 | 0.63542649 |
| 109 | IRAK3 | 0.61726934 |
| 110 | IRAK4 | 0.59823384 |
| 111 | PIK3CG | 0.58694559 |
| 112 | MAPKAPK5 | 0.58439955 |
| 113 | ZAK | 0.57949030 |
| 114 | MATK | 0.56944536 |
| 115 | LATS2 | 0.56936487 |
| 116 | EPHA2 | 0.56851352 |
| 117 | CDK14 | 0.56749930 |
| 118 | ACVR1B | 0.56041100 |
| 119 | INSRR | 0.55525573 |
| 120 | FGFR4 | 0.54965229 |
| 121 | KSR2 | 0.52913925 |
| 122 | NUAK1 | 0.51851840 |
| 123 | TRPM7 | 0.51695229 |
| 124 | EPHA3 | 0.51625738 |
| 125 | PAK4 | 0.51410920 |
| 126 | CSK | 0.51114355 |
| 127 | BRSK2 | 0.50534891 |
| 128 | PRKCI | 0.50110181 |
| 129 | NEK2 | 0.48894800 |
| 130 | SGK223 | 0.48822837 |
| 131 | SGK494 | 0.48822837 |
| 132 | RPS6KA5 | 0.48570170 |
| 133 | MAP3K11 | 0.48480428 |
| 134 | PRKCQ | 0.48228464 |
| 135 | ERBB3 | 0.47564256 |
| 136 | MAPK13 | 0.47210106 |
| 137 | CCNB1 | 0.46773155 |
| 138 | TESK1 | 0.46258391 |
| 139 | NME1 | 0.45987473 |
| 140 | TAOK1 | 0.45527940 |
| 141 | STK10 | 0.44015210 |
| 142 | CAMK2D | 0.43641596 |
| 143 | TBK1 | 0.43104194 |
| 144 | LATS1 | 0.42228822 |
| 145 | NTRK1 | 0.41563506 |
| 146 | SCYL2 | 0.41451316 |
| 147 | MUSK | 0.41330683 |
| 148 | CLK1 | 0.41048631 |
| 149 | RPS6KA4 | 0.40724934 |
| 150 | PRKCE | 0.39841992 |
| 151 | LCK | 0.39697759 |
| 152 | TYK2 | 0.39625252 |
| 153 | STK16 | 0.39458556 |
| 154 | PDK1 | 0.39337412 |
| 155 | DYRK3 | 0.39030694 |
| 156 | RIPK4 | 0.38923740 |
| 157 | DAPK3 | 0.38671047 |
| 158 | CAMK2B | 0.37531144 |
| 159 | PLK4 | 0.37103592 |
| 160 | PTK2B | 0.36898580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.95936253 |
| 2 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.34196047 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.17148800 |
| 4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.06584772 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.95803621 |
| 6 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.81370635 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.75830080 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.63462492 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 2.43274597 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.27985723 |
| 11 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.21911037 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.20921385 |
| 13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.19892506 |
| 14 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.03881237 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.02581988 |
| 16 | Huntingtons disease_Homo sapiens_hsa05016 | 1.98816638 |
| 17 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.94033773 |
| 18 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.89991639 |
| 19 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.84296832 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.84004456 |
| 21 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.81209866 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.80852339 |
| 23 | Lysosome_Homo sapiens_hsa04142 | 1.74141177 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.73302783 |
| 25 | Sulfur relay system_Homo sapiens_hsa04122 | 1.71712626 |
| 26 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.69731049 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.55735566 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.55271327 |
| 29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.49426117 |
| 30 | RNA polymerase_Homo sapiens_hsa03020 | 1.40943039 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.36305033 |
| 32 | Asthma_Homo sapiens_hsa05310 | 1.35311324 |
| 33 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.34771083 |
| 34 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.32664630 |
| 35 | Allograft rejection_Homo sapiens_hsa05330 | 1.29366299 |
| 36 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.25674599 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.24930243 |
| 38 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24656875 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.24508304 |
| 40 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.24378966 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.23728754 |
| 42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.22007351 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.19653964 |
| 44 | Platelet activation_Homo sapiens_hsa04611 | 1.19625773 |
| 45 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.17396793 |
| 46 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.16255617 |
| 47 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.15620583 |
| 48 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.14075148 |
| 49 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.13120499 |
| 50 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.12858077 |
| 51 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.10711728 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.09917244 |
| 53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.05148732 |
| 54 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.05104348 |
| 55 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.04591231 |
| 56 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.02351733 |
| 57 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.00568133 |
| 58 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.96841091 |
| 59 | Histidine metabolism_Homo sapiens_hsa00340 | 0.96065156 |
| 60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.94469845 |
| 61 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.92643982 |
| 62 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.91715516 |
| 63 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.90647569 |
| 64 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.88094827 |
| 65 | Protein export_Homo sapiens_hsa03060 | 0.86583918 |
| 66 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.85989868 |
| 67 | Ribosome_Homo sapiens_hsa03010 | 0.83720124 |
| 68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.83249774 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.82298116 |
| 70 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.82250326 |
| 71 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.80574484 |
| 72 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.79492079 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.77346727 |
| 74 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.75824543 |
| 75 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75373413 |
| 76 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.73771592 |
| 77 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.73406746 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.73093227 |
| 79 | Phagosome_Homo sapiens_hsa04145 | 0.72699175 |
| 80 | Homologous recombination_Homo sapiens_hsa03440 | 0.72596512 |
| 81 | Malaria_Homo sapiens_hsa05144 | 0.70911391 |
| 82 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.69878347 |
| 83 | Legionellosis_Homo sapiens_hsa05134 | 0.67724235 |
| 84 | Other glycan degradation_Homo sapiens_hsa00511 | 0.67472028 |
| 85 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.67266619 |
| 86 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.65151659 |
| 87 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.63423106 |
| 88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62763529 |
| 89 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.60783203 |
| 90 | Basal transcription factors_Homo sapiens_hsa03022 | 0.60088612 |
| 91 | Mineral absorption_Homo sapiens_hsa04978 | 0.59996316 |
| 92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.59537601 |
| 93 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.58885146 |
| 94 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.58168996 |
| 95 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.57953176 |
| 96 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.57939601 |
| 97 | Parkinsons disease_Homo sapiens_hsa05012 | 0.53706523 |
| 98 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.50915146 |
| 99 | Phototransduction_Homo sapiens_hsa04744 | 0.50405193 |
| 100 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.48433118 |
| 101 | Bile secretion_Homo sapiens_hsa04976 | 0.48189285 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48107336 |
| 103 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.46587896 |
| 104 | Retinol metabolism_Homo sapiens_hsa00830 | 0.46279651 |
| 105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.46237387 |
| 106 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.43432907 |
| 107 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.42637947 |
| 108 | Tuberculosis_Homo sapiens_hsa05152 | 0.41362119 |
| 109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41219812 |
| 110 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.40943801 |
| 111 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.39983114 |
| 112 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.39091314 |
| 113 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38773179 |
| 114 | Shigellosis_Homo sapiens_hsa05131 | 0.38639985 |
| 115 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.35598304 |
| 116 | Alzheimers disease_Homo sapiens_hsa05010 | 0.34932184 |
| 117 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.34430636 |
| 118 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.33932086 |
| 119 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.33201174 |
| 120 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.32467650 |
| 121 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.30909023 |
| 122 | Prion diseases_Homo sapiens_hsa05020 | 0.30826522 |
| 123 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.30289677 |
| 124 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.29832585 |
| 125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.29387361 |
| 126 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.27966261 |
| 127 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.27799344 |
| 128 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.27481179 |
| 129 | Purine metabolism_Homo sapiens_hsa00230 | 0.26937848 |
| 130 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.26643233 |
| 131 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.25906126 |
| 132 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24555260 |
| 133 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.23126047 |
| 134 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.21686502 |
| 135 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.21018731 |

